Heron Therapeutics, Inc.
HRTX
$0.84
-$0.03-3.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.63M | 55.49M | 40.63M | 50.68M | 59.28M |
| Total Receivables | 89.59M | 81.05M | 79.93M | 78.74M | 78.88M |
| Inventory | 92.75M | 70.03M | 72.97M | 56.93M | 53.16M |
| Prepaid Expenses | 9.10M | 22.84M | 17.39M | 26.49M | 17.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 238.07M | 229.40M | 210.92M | 212.84M | 209.01M |
|
|
|||||
| Total Current Assets | 238.07M | 229.40M | 210.92M | 212.84M | 209.01M |
| Net Property, Plant & Equipment | 12.40M | 13.67M | 15.08M | 16.63M | 17.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.41M | 5.88M | 6.08M | 6.28M | 6.48M |
| Total Assets | 255.88M | 248.95M | 232.09M | 235.75M | 233.15M |
|
|
|||||
| Total Accounts Payable | 8.99M | 12.02M | 12.04M | 12.33M | 11.71M |
| Total Accrued Expenses | 87.10M | 72.42M | 65.54M | 69.77M | 76.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 780.00K | 176.74M | 2.29M | 3.04M |
| Total Finance Division Other Current Liabilities | -- | 4.49M | 4.28M | 4.16M | -- |
| Total Other Current Liabilities | -- | 4.49M | 4.28M | 4.16M | -- |
| Total Current Liabilities | 96.10M | 89.71M | 258.60M | 88.56M | 91.46M |
|
|
|||||
| Total Current Liabilities | 96.10M | 89.71M | 258.60M | 88.56M | 91.46M |
| Long-Term Debt | 140.64M | 139.66M | -- | 174.97M | 174.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.81M | 4.69M | 747.00K | 682.00K | 615.00K |
| Total Liabilities | 241.54M | 234.07M | 259.35M | 264.21M | 266.80M |
|
|
|||||
| Common Stock & APIC | 1.95B | 1.94B | 1.89B | 1.89B | 1.89B |
| Retained Earnings | -1.94B | -1.94B | -1.92B | -1.92B | -1.92B |
| Treasury Stock & Other | 4.00K | -- | -1.00K | 1.00K | 13.00K |
| Total Common Equity | 13.28M | 7.02M | -27.26M | -28.45M | -33.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.05M | 7.86M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.05M | 7.86M | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.28M | 7.02M | -27.26M | -28.45M | -33.65M |
| Total Preferred Equity | 1.05M | 7.86M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.33M | 14.89M | -27.26M | -28.45M | -33.65M |
|
|
|||||